COPD Archives - Healthentia https://healthentia.com/tag/copd/ Fri, 04 Jul 2025 10:49:01 +0000 en-US hourly 1 https://healthentia.com/wp-content/uploads/2020/04/cropped-favicon_512-32x32.png COPD Archives - Healthentia https://healthentia.com/tag/copd/ 32 32 193384636 Transforming COPD Care with Healthentia: Empowering Patients and Providers through Real-World Insights https://healthentia.com/transforming-copd-care-with-healthentia-empowering-patients-and-providers-through-real-world-insights/ Wed, 20 Nov 2024 08:22:18 +0000 https://healthentia.com/?p=20589   Managing chronic obstructive pulmonary disease (COPD) alongside other chronic conditions (CCs) like depression requires a comprehensive and innovative approach. As part of the RE-SAMPLE research project, Healthentia, our advanced SaMD solution, addresses this challenge by integrating real-world data (RWD) to enhance disease management and improve daily life for patients. For more information about the...

The post Transforming COPD Care with Healthentia: Empowering Patients and Providers through Real-World Insights appeared first on Healthentia.

]]>
 

Managing chronic obstructive pulmonary disease (COPD) alongside other chronic conditions (CCs) like depression requires a comprehensive and innovative approach. As part of the RE-SAMPLE research project, Healthentia, our advanced SaMD solution, addresses this challenge by integrating real-world data (RWD) to enhance disease management and improve daily life for patients. For more information about the intended use of the device and the medical modules, please consult: https://healthentia.com/medical-device/

This research-driven initiative bridges the gap between clinical research and real-world healthcare, supporting two phases of COPD and CCs management:

  • Phase 1: Healthentia collects RWD to track disease progression, uncover patterns, and predict exacerbations. These insights enable proactive care, empowering healthcare providers to anticipate and address patient needs more effectively.
  • Phase 2: Through its Virtual Companionship Program (VCP), the platform delivers tailored self-management tools, including lifestyle coaching, goal-setting, and real-time medical suggestions. Patients gain the confidence to manage their health actively, while healthcare providers benefit from actionable insights via a clinical dashboard. This enables personalized, adaptive care strategies, ensuring better outcomes.

Healthentia redefines the standard of COPD care in hospitals across Europe by seamlessly integrating real-world insights with technology-driven solutions. By prioritizing both patients and providers, it transforms the approach to managing not only COPD but also co-existing chronic conditions, helping patients regain control over their health and well-being.

This World COPD Day, Healthentia reaffirms its commitment to innovation, providing hope and support for millions living with COPD.

The post Transforming COPD Care with Healthentia: Empowering Patients and Providers through Real-World Insights appeared first on Healthentia.

]]>
20589
The Role of Big Data and Artificial Intelligence in Clinical Research and Digital Therapeutics https://healthentia.com/acceptance-and-potential-impact-of-the-ewall-platform-copy/ Mon, 28 Aug 2023 13:06:29 +0000 https://healthentia.com/?p=20080 CATEGORY: Artificial Intelligence, Big data, Clinical research, Real-World Data, Digital therapeutics SOURCE: Personalized Medicine Meets Artificial Intelligence. Springer, Cham. https://doi.org/10.1007/978-3-031-32614-1_6 The Role of Big Data and Artificial Intelligence in Clinical Research and Digital Therapeutics Kyriazakos S., Pnevmatikakis A., op den Akker H., Kostopoulou K. (2023), In: Cesario, A., D’Oria, M., Auffray, C., Scambia, G. (eds)...

The post The Role of Big Data and Artificial Intelligence in Clinical Research and Digital Therapeutics appeared first on Healthentia.

]]>

CATEGORY: Artificial Intelligence, Big data, Clinical research, Real-World Data, Digital therapeutics SOURCE: Personalized Medicine Meets Artificial Intelligence. Springer, Cham. https://doi.org/10.1007/978-3-031-32614-1_6

The Role of Big Data and Artificial Intelligence in Clinical Research and Digital Therapeutics

Kyriazakos S., Pnevmatikakis A., op den Akker H., Kostopoulou K. (2023), In: Cesario, A., D’Oria, M., Auffray, C., Scambia, G. (eds) Abstract Healthcare is among the pioneering industries in the velocity of generation of big data, from the time that Electronic Health Records, Internet-of-Things, and electronic medical devices have been introduced. Researchers around the world are curating large volumes of data and applying Artificial Intelligent (AI) algorithms that give meaning to medical conditions, as well as prediction of clinical outcomes. The clinical research domain, which has been a laggard in digital transformation, is running today at high speed, utilizing electronic solutions that enable capturing of Real-World Data (RWD) in decentralized virtual clinical studies that aim to shorten the life cycle of drug development and the associated costs. At the same time, the domain of Digital Therapeutics (DTx) has been recently established, with various electronic solutions that process RWD to provide digital interventions that improve health-related endpoints. In this chapter, we will review how clinical research and DTx domains have been accelerated by the existence of Big data and AI algorithms and we will describe smart services that are expected to further boost the healthcare industry. Keywords: Artificial Intelligence, Big data, Clinical research, Real-World Data, Digital therapeutics

More Publications

The post The Role of Big Data and Artificial Intelligence in Clinical Research and Digital Therapeutics appeared first on Healthentia.

]]>
20080
Acceptance and Potential Impact of the eWALL Platform for Health Monitoring and Promotion in Persons with a Chronic Disease or Age-Related Impairment https://healthentia.com/acceptance-and-potential-impact-of-the-ewall-platform/ Wed, 29 Mar 2023 13:22:48 +0000 https://healthentia.com/?p=19768 CATEGORY: eHealth, Health monitoring, telemonitoring, COPD Remote patient monitoring SOURCE: Int. J. Environ. Res. Public Health 2020, 17(21), 7893; https://doi.org/10.3390/ijerph17217893 Acceptance and Potential Impact of the eWALL Platform for Health Monitoring and Promotion in Persons with a Chronic Disease or Age-Related Impairment Francesco Infarinato, Stephanie Jansen-Kosterink, Paola Romano, Lex van Velsen, Harm op den Akker, Federica Rizza, Marco Ottaviani, Sofoklis Kyriazakos, Beatrix Wais-Zechmann, Markus Garschall, Stefano Bonassi,...

The post Acceptance and Potential Impact of the eWALL Platform for Health Monitoring and Promotion in Persons with a Chronic Disease or Age-Related Impairment appeared first on Healthentia.

]]>

CATEGORY: eHealth, Health monitoring, telemonitoring, COPD Remote patient monitoring

SOURCE: Int. J. Environ. Res. Public Health 2020, 17(21), 7893; https://doi.org/10.3390/ijerph17217893

Acceptance and Potential Impact of the eWALL Platform for Health Monitoring and Promotion in Persons with a Chronic Disease or Age-Related Impairment

Francesco Infarinato, Stephanie Jansen-Kosterink, Paola Romano, Lex van Velsen, Harm op den Akker, Federica Rizza, Marco Ottaviani, Sofoklis Kyriazakos, Beatrix Wais-Zechmann, Markus Garschall, Stefano Bonassi, and Hermie J. Hermens

Abstract

Pervasive health technologies can increase the effectiveness of personal health monitoring and training, but more user studies are necessary to understand the interest for these technologies, and how they should be designed and implemented. In the present study, we evaluated eWALL, a user-centered pervasive health technology consisting of a platform that monitors users' physical and cognitive behavior, providing feedback and motivation via an easy-to-use, touch-based user interface. The eWALL was placed for one month in the home of 48 subjects with a chronic condition (chronic obstructive pulmonary disease-COPD or mild cognitive impairment-MCI) or with an age-related impairment. User acceptance, platform use, and potential clinical effects were evaluated using surveys, data logs, and clinical scales. Although some features of the platform need to be improved before reaching technical maturity and making a difference in patients' lives, the real-life evaluation of eWALL has shown how some features may influence patients' intention to use this promising technology. Furthermore, this study made it clear how the free use of different health apps is modulated by the real needs of the patient and by their usefulness in the context of the patient's clinical status.

The post Acceptance and Potential Impact of the eWALL Platform for Health Monitoring and Promotion in Persons with a Chronic Disease or Age-Related Impairment appeared first on Healthentia.

]]>
19768
eWALL: An Open-Source Cloud-Based eHealth Platform for Creating Home Caring Environments for Older Adults Living with Chronic Diseases or Frailty https://healthentia.com/ewall-an-open-source-cloud-based-ehealth-platform/ Wed, 29 Mar 2023 13:13:33 +0000 https://healthentia.com/?p=19751 CATEGORY: eHealth, eCare, Personal Health Systems, COPD, MCI, Frailty Assistant, Remote patient monitoring SOURCE: Wireless Pers Commun 97, 1835-1875 (2017). https://doi.org/10.1007/s11277-017-4656-7 eWALL: An Open-Source Cloud-Based eHealth Platform for Creating Home Caring Environments for Older Adults Living with Chronic Diseases or Frailty Sofoklis Kyriazakos, Ramjee Prasad, Albena Mihovska, Aristodemos Pnevmatikakis, Harm op den Akker, Hermie Hermens, Paolo Barone, Alessandro Mamelli, Samuele de Domenico, Matthias Pocs, Andrej...

The post eWALL: An Open-Source Cloud-Based eHealth Platform for Creating Home Caring Environments for Older Adults Living with Chronic Diseases or Frailty appeared first on Healthentia.

]]>

CATEGORY: eHealth, eCare, Personal Health Systems, COPD, MCI, Frailty Assistant, Remote patient monitoring
SOURCE: Wireless Pers Commun 97, 1835-1875 (2017). https://doi.org/10.1007/s11277-017-4656-7

eWALL: An Open-Source Cloud-Based eHealth Platform for Creating Home Caring Environments for Older Adults Living with Chronic Diseases or Frailty

Sofoklis KyriazakosRamjee PrasadAlbena MihovskaAristodemos PnevmatikakisHarm op den AkkerHermie HermensPaolo BaroneAlessandro MamelliSamuele de DomenicoMatthias PocsAndrej GrguricMiran MosmondorDina SimunicAntun KernerNikola ZaricMilica Pejanović-DjurišićVladimir PoulkovKrasimir TochevBeatrix ZechmannMarkus GarschallAngeliki AngeletouStefano BonassiFrancesco InfarinatoOctavian FratouAlexandru VulpeCarmen VoicuLiljana Gavrilovska & Vladimir Atanasovski

Abstract

Independent living of older adults is one of the main challenges linked to the ageing population. Especially those living with diseases like COPD, MCI or frailty, need more support in everyday life and this is by itself a big societal challenge with impact in multiple sectors. In this paper we present eWALL, an innovative open-source eHealth platform that aims to address these challenges by means of an advanced cloud-based infrastructure. eWALL is designed in an innovative manner and achieved technical breakthroughs in eHealth platforms, while prioritizing user and market needs that are often abandoned and are the major reason for technically sound solutions that fail. We consider this as an opportunity and we aim to change the eHealth systems' experience for older adults and break the barriers for the penetration of ICT solutions.

The post eWALL: An Open-Source Cloud-Based eHealth Platform for Creating Home Caring Environments for Older Adults Living with Chronic Diseases or Frailty appeared first on Healthentia.

]]>
19751
Innovation Radar Prize 2022 – Disruptive Health https://healthentia.com/innovation-radar-prize-2022-disruptive-health/ Tue, 18 Oct 2022 14:13:03 +0000 https://healthentia.com/?p=19505 We are excited that Innovation Sprint is short-listed for the Innovation Radar Award on Disruptive Health, together with 9 other companies. Since 2015 the European Commission has been awarding the annual Innovation Radar Prize to great EU-funded innovators, putting a spotlight on the high-potential innovations they are trying to get "out of the lab and...

The post Innovation Radar Prize 2022 – Disruptive Health appeared first on Healthentia.

]]>

We are excited that Innovation Sprint is short-listed for the Innovation Radar Award on Disruptive Health, together with 9 other companies.

Since 2015 the European Commission has been awarding the annual Innovation Radar Prize to great EU-funded innovators, putting a spotlight on the high-potential innovations they are trying to get "out of the lab and into the market". Intelligence gathered by the Innovation Radar is used to identify innovators who can then compete for the prize. 

The top innovation finalists are grouped into 3 categories of 10 each, out of a tremendous number of applications for the 2022 Innovation Radar Prize. The 3 categories are: 

  • Disruptive Health 
  • Purpose-driven & Green 
  • Kickstarter 

The Innovation Radar Prize 2022 includes voting from the public, which will assist the jury in their search for the best innovation of 2022.   

Innovation Sprint is one of the 10 candidates for the Innovation Prize of Disruptive Health and we are looking forward to receiving your vote here. 

Innovation Radar Prize 2022
Vote for Innovation Sprint

Why have we been selected as finalists?  

Sofoklis Kyriazakos, CEO of Innovation Sprint, explains the reasons that brought Innovation Sprint to the final of the Innovation Radar Prize 2022.

Innovation is part of our company name, but foremost it is part of our DNA. Our purpose to improve health outcomes and outperform existing therapeutic care-paths using innovative technologies, has been an exciting and long journey from the day we started until where we are now commercializing our novel MedTech product in this highly regulated and challenging domain. Our product Healthentia, is a certified Software as Medical Device that uses best of breed of Internet, IoT, AI, and Big Data technologies together with clinical and regulatory knowledge to support healthcare professionals to monitor their patients, through digital clinical pathways addressing chronic conditions. Healthentia has been used so far in patient cohorts with cancer, heart failure, COPD, Covid-19, HIV, and other conditions. The clinical evidence that has been captured so far demonstrates increased adherence to treatment and Quality of Life, while we are currently running clinical studies, in which we monitor endpoints like mortality and rehospitalization. In Belgium, we are already at level 2 of the mHealthBELGIUM pyramid link, which paves the way towards reimbursement. We have market authorization for Europe and we have finalized the PreSub evaluation from FDA for 510(k) clearance.  This journey was strongly influenced by our research activities, many of them performed under EC R&D projects, which contributed to the inclusion of key innovations in Healthentia and bringing the product to another level; a level that is backed up by science. We are committed to continuously improving Healthentia to disrupt health, by outperforming traditional treatments, thus contributing to Good Health and Wellbeing, one of the key sustainability goals of the UNIn this trajectory, we will continue to improve Healthentia in a way to address demanding market needs, regulatory challenges, while implementing our purpose to use innovative technologies to improve health outcomes and outperform existing therapeutic care paths. 

 

What are the key innovations so far? 

Aristodemos Pnevmatikakis, R&D Director of Innovation Sprint, explains Healthentia smart services and the role of EU co-funded projects in implementing them. 

Healthentia is a secure big data platform for patient data, providing two applications to its two categories of end-users: a) Patients use the mobile app to facilitate the collection of their data and delivery of info and feedback, and b) healthcare professionals use the portal app to setup studies or programs to monitor their patients both as a cohort, or as individuals. Both applications are empowered by smart services: On the one hand, clinicians can handle patients in clusters and get insights from inference on models learnt on patients’ data. On the other hand, patients benefit from feedback on important attributes in their data, as these attributes are highlighted by explainable AI techniques. 

EU co-funded projects have been playing a dual role in Healthentia. Looking back at our origins, the company started as the exploitation output of the eWALL project. Many more recent and ongoing projects have been instrumental in the implementation of our smart services. They allow us to run studies across Europe, increasing our volume and diversity of subjects, thus reducing the bias in the models we can learn from the collected data. They also facilitate early testing of our models in prototypes of our smart services. Last but not least, they facilitate our scientific output, by providing us with collaboration opportunities and funding for publications.

At Innovation Sprint we commit to providing patients and professionals with continuously improved smart services, aiming at helping the former improve the life of the latter. 

 

How do we combine innovation with needs? 

Konstantina Kostopoulou, Chief Product Officer of Innovation Sprint, explains how Healthentia has evolved into the solution it is today by combining innovation with the different stakeholder’s needs from the market.

Healthentia has been developed through participatory design and evaluation from stakeholders. Both the application for the patients and the portal for the clinicians are co-designed with patient focus groups and workshops with clinicians. In this product development journey, we have done user studies and interviewed patient focus groups after asking them to accomplish a set of tasks on the mobile app. They have evaluated the easiness and experience of using Healthentia. For similar tasks their valuable feedback is collected for feature optimizations. Regarding the clinician portal, regular sessions are taking place to collect feedback from clinicians to address their needs and optimize the assessment of a patients’ health state. We work together with clinicians from customizing their dashboards or enhance their patient record with selected clinical date from a hospital’s EMR. The Healthcare market include a great range of Stakeholders including but not limiting to, patients, caregivers, doctors, nurses, patient organizations, government, insurance companies, communities and pharmaceutical firms. Our collaborations within this market influence our product roadmap to meet the needs and expectations in this changing environment of digital Health.

The post Innovation Radar Prize 2022 – Disruptive Health appeared first on Healthentia.

]]>
19505
RE-SAMPLE https://healthentia.com/re-sample/ Tue, 04 Jan 2022 13:47:15 +0000 https://healthentia.com/?p=19056 Study Description Shared-decision making for tailored Comorbid Complex Chronic (CCC) disease management, crossing care paths towards daily life, and early proper treatment to prevent CCC disease progression. Identify individual multi-morbid CCC exacerbations and develop tailored referrals to a multidisciplinary, adaptive virtual companionship program for COPD patients with CCCs. The RWD from daily life measurements and...

The post RE-SAMPLE appeared first on Healthentia.

]]>

Study Description

Shared-decision making for tailored Comorbid Complex Chronic (CCC) disease management, crossing care paths towards daily life, and early proper treatment to prevent CCC disease progression. Identify individual multi-morbid CCC exacerbations and develop tailored referrals to a multidisciplinary, adaptive virtual companionship program for COPD patients with CCCs.

The RWD from daily life measurements and existing medical knowledge-base will be integrated based on inclusive models representing e.g. patients, healthcare (providers), scientists, policymakers, and industry. The RE-SAMPLE study develop privacy-securing data management and AI prediction modeling to tailor local personalised treatment programs using accurate predictions of multi-morbid exacerbations and personalised interventions.

Study Details

  • Type: Research
  • Disease: COPD and Comorbid Complex Chronic Conditions (CCCs)
  • Sites: The Netherlands, Italy, Estonia
  • Start: March 2021
  • Population: 710 patients
  • Duration: 48 months

Study Design & Method

Patients will receive an activity tracker (i.e monitoring bracelet) that will collect at a daily basis Real-World Data like activity (i.e. steps per day), sleep, and vital signs. The device will be delivered during the recruitment, and each patient/participant will pair the device through the Healthentia application downloaded on the smartphone.

During the whole observation period, patients will report through weekly dedicated questionnaires for RWD collection and management mechanisms. Also, the study aims to implement and test the real-time predictions of the RE-SAMPLE-trained models applied to new data. 

9122021(2)

RWD to monitor COPD symptoms beyond scheduled medical check-ups

9122021(1)

Personalised treatment and a virtual companionship programme

9122021(1)

Multidisciplinary approach (respiratory medicine, AI, RWD, privacy, ethics, data protection, health policy)

The post RE-SAMPLE appeared first on Healthentia.

]]>
19056
Acceptance and Potential Impact of the eWALL Platform for Health Monitoring and Promotion in Persons with a Chronic Disease or Age-Related Impairment https://healthentia.com/acceptance-and-potential-impact-of-the-ewall-platform-for-health-monitoring-and-promotion-in-persons-with-a-chronic-disease-or-age-related-impairment/ Sun, 10 Jan 2021 14:41:11 +0000 https://healthentia.com/?p=18737 Topics: eHealth, Devices, e-Health applications SOURCE: MDPI Open Access Journals, 2020, Oct. ;  BOOK DOI Link, Chapter DOI Link Acceptance and Potential Impact of the eWALL Platform for Health Monitoring and Promotion in Persons with a Chronic Disease or Age-Related Impairment Francesco Infarinato 1 ; Stephanie Jansen-Kosterink 2 ; Paola Romano 1 ; Lex van...

The post Acceptance and Potential Impact of the eWALL Platform for Health Monitoring and Promotion in Persons with a Chronic Disease or Age-Related Impairment appeared first on Healthentia.

]]>

Topics: eHealth, Devices, e-Health applications

SOURCE: MDPI Open Access Journals, 2020, Oct. ;  BOOK DOI Link, Chapter DOI Link

Acceptance and Potential Impact of the eWALL Platform for Health Monitoring and Promotion in Persons with a Chronic Disease or Age-Related Impairment

Francesco Infarinato 1 ; Stephanie Jansen-Kosterink 2 ; Paola Romano 1 ; Lex van Velsen 2 ; Harm op den Akker 2 ; Federica Rizza 1 ; Marco Ottaviani 1 ; Sofoklis Kyriazakos 3,4 ; Beatrix Wais-Zechmann 5 ; Markus Garschall 5 ; Stefano Bonassi 1,6 ; Hermie J. Hermens 2

Abstract

Pervasive health technologies can increase the effectiveness of personal health monitoring and training, but more user studies are necessary to understand the interest for these technologies, and how they should be designed and implemented. In the present study, we evaluated eWALL, a user-centered pervasive health technology consisting of a platform that monitors users’ physical and cognitive behavior, providing feedback and motivation via an easy-to-use, touch-based user interface. The eWALL was placed for one month in the home of 48 subjects with a chronic condition (chronic obstructive pulmonary disease—COPD or mild cognitive impairment—MCI) or with an age-related impairment. User acceptance, platform use, and potential clinical effects were evaluated using surveys, data logs, and clinical scales. Although some features of the platform need to be improved before reaching technical maturity and making a difference in patients’ lives, the real-life evaluation of eWALL has shown how some features may influence patients’ intention to use this promising technology. Furthermore, this study made it clear how the free use of different health apps is modulated by the real needs of the patient and by their usefulness in the context of the patient’s clinical status.

Keywords: eHealth; telemonitoring; telerehabilitation; ICT platform; acceptance of technology; user experience; MCI; COPD; chronicity; frailty; patient empowerment; pervasive healthcare; health apps

The post Acceptance and Potential Impact of the eWALL Platform for Health Monitoring and Promotion in Persons with a Chronic Disease or Age-Related Impairment appeared first on Healthentia.

]]>
18737